Impact of doxycycline (doxy) prophylaxis on dermatologic toxicity from dacomitinib (D) for NSCLC, by CTCAE and patient (pt)-reported outcomes (PRO) measures in a placebo-controlled trial Meeting Abstract


Authors: Lacouture, M.; Grunberg, S.; Keefe, D.; Sonis, S.; Ely, J.; Gernhardt, D.; Wang, T.; Doherty, J.; O'Connell, J.; Jatoi, A.
Abstract Title: Impact of doxycycline (doxy) prophylaxis on dermatologic toxicity from dacomitinib (D) for NSCLC, by CTCAE and patient (pt)-reported outcomes (PRO) measures in a placebo-controlled trial
Meeting Title: 17th European Cancer Conference (ECCO 17)
Journal Title: European Journal of Cancer
Volume: 49
Issue: Suppl. 2
Meeting Dates: 2013 Sep 27-Oct 1
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2013-09-01
Start Page: S817
Language: English
ACCESSION: WOS:000326843605187
PROVIDER: wos
DOI: 10.1016/S0959-8049(13)70065-0
Notes: Meeting Abstract: 3466 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture